Fresenius Medical Care's Results Are Solid But U.S. Dialysis Treatment Growth Disappoints -- Market Talk
Dow Jones
May 06, 2025
0704 GMT - Fresenius Medical Care's better-than-expected results are solid but its U.S. dialysis treatment growth disappoints, Deutsche Bank analysts say in a note. The German dialysis company's closely watched underlying U.S. same-market treatment growth was flat due to a severe flu season leading to higher mortality among potential patients, the analysts say. Its backed outlook is a positive but foreign-currency exchanges should still put pressure on consensus earnings estimates, they say. (helena.smolak@wsj.com)
(END) Dow Jones Newswires
May 06, 2025 03:06 ET (07:06 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
At the request of the copyright holder, you need to log in to view this content
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.